Indication and selection of pediatric patients for genetically modified T cells

for the SBTMO Technical manual of cellular therapy

Authors

  • Adriana Seber

DOI:

https://doi.org/10.46765/2675-374X.2022v3n2p173

Keywords:

chimeric antigen receptor, acute lymphoblastic leukemia, pediatric, hematopoietic stem cell transplantation

Abstract

The use of CAR-T cells will completely change the treatment of many hematological diseases, including relapsed pediatric B-lineage acute lymphoblastic leukemia. This article is part of the Brazilian Society of Bone Marrow Transplantation (SBTMO)’s “Technical manual of cellular therapy” to guide physicians to select patients and indicate the use of the CAR-T cells in pediatric patients with acute lymphoblastic leukemia. Other aspects of CAR-T cell therapy and management of important toxicities are included on other articles of this volume.

Downloads

Published

11/23/2022

How to Cite

Seber, A. (2022). Indication and selection of pediatric patients for genetically modified T cells : for the SBTMO Technical manual of cellular therapy. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 3(2), 173. https://doi.org/10.46765/2675-374X.2022v3n2p173

Most read articles by the same author(s)

<< < 1 2 

Similar Articles

You may also start an advanced similarity search for this article.